ABSTRACT: Among the mouse-human hybrids prepared In our laboratory one clone was found to contain only human chromosome 5 with an Integrated selectable marker. This monochromosomal hybrid was used to Investigate different aspects related to the toxlclty of diphtheria toxin (DT). The hybrid was as sensitive to diphtheria toxin as the human donor cells. The protective effect of NH4CI against diphtheria toxin could be demonstrated In the hybrid and also in the mouse and human cell lines. The reversal of the protective NH4CI effect at acid pH also could be demonstrated In all three cell types. Incubation of cells with 125 l-dlphtherla toxin at 37°C In the presence of methylamlne showed a time-dependent Increase In specific association In the human and the hybrid but not in the mouse cell line. The results obtained for the first time on a stable monochromosomal hybrid suggest that chromosome 5 Is both necessary and sufficient for the expression of DT sensitivity.
toxicity to mammalian cells by inhibition of protein synthesis 4 ' 30 . The inhibition is due to the catalytic cleavage of ADP-ribose from N AD + and the covalent binding of the ADPribose moiety to elongation factor-2 (EF-2), thereby inactivating it. If the whole toxin molecule (58 342 daltons) is subjected to limited proteolysis and reduction, two fragments with different biological activities arc obtained. Fragment A, (21 162 daltons), which comprises the amino terminal end of the DT molecule, has the catalytic activity, while fragment B (37 195 daltons), the remaining portion of the molecule, serves to bind the toxin to its cell surface receptors and to translocate it into the cytoplasm 4 ' u ' 30 . While human cells in general are sensitive to DT, mouse cells are resistant, but the resistance can be overcome by increasing concentrations of DT 28 . In human cells, the gene(s) coding for the sensitivity to DT is mapped on chromosome 5 and the presence of chromosome 5 in mouse X human hybrids is associated with increased sensitivity to DT 6 . Since the EF-2 from human and mouse cells can be ribosylated to the same extent in a cell free system 26 , the information present on chromosome 5 must code for factor(s) associated with uptake and/or processing of DT. The generation of a stable human-mouse monochromosomal hybrid containing human chromosome 5, gave us an opportunity to study the parameters associated with the uptake and the expression of DT toxicity in the hybrid and compare them with the donor and recipient cells.
Materials and Methods
The following cell lines were used in these studies. A human line, MGH-1, was the kind gift of Dr. George R. Prout Jr., Professor of Surgery, Harvard Medical School. RAG, a mouse hprt" line, was purchased from American Type Culture Collection, (ATCC, Cat.#CCL-142). The MGH-1 cell line served as a donor for chromosome transfer into RAG cells and the generation of hybrid cells containing human chromosomes. The particular hybrid clone, R12-2, used in these studies contained only a single human chromosome transferred from MGH-1. A brief description of the production of hybrids is given here, while a detailed account will be published elsewhere 1 . A dominant selectable marker, E. coli xanthine-guanine phosphoribosyltransferase (Ecogpt) gene cloned into a plasmid pSV2gpt M was first transferred into MGH-1 cells by DNA transfection procedure 35 . The gene transfer clones were isolated by selec-tion for growth in medium containing mycophenolic acid and xanthine as described by Mulligan and Berg 29 . Gene transfer clones expressing the transferred gene were cultured continuously in the selective medium for 20-30 cell generations to promote the integration of the transferred gene and then recloned to produce clonal cell lines each carrying the pSV2gpt integrated into a different site 1 . Microcells 12 prepared from one of these clones were fused with RAG cells and microcell hybrids were isolated by selection for growth in medium containing mycophenolic acid and xanthine.
MGH-1 and RAG cells were routinely cultured at 37°C in 10 percent CO 2 using Dulbecco's Modified Eagle's Medium containing 10 percent fetal calf serum (DME). The monochromosomal hybrid R12-2 was cultured in DME containing the selective agents, mycophenolic acid (25 /xg/ml) and xanthine (100 jig/ml), designated as MX medium.
Human chromosomes, present in microcell hybrids were identified by cytogenetic and biochemical means. For cytogenetic analysis cells cultured in 100 mm tissue culture dishes were blocked in mitosis with Colcemid (0.1 fig/ml) for 2 hours. Mitotic cells, preferentially harvested by shaking the plates, were swollen in KC1 (0.075 M) for 15 minutes at 37°C and fixed in three sequential changes of fixative (methanol: glacial acetic acid, 3:1). Metaphase spreads prepared by air drying were analyzed by staining with Giemsa-11 2 and Giemsa banding 33 .
To stain for Giemsa 11 (G-ll) one-dayold slides were soaked in water at 37°C for 30 minutes and then rinsed in 0.05 M sodium phosphate buffer (pH 11.3) for 1 minute. Following pretreatment, slides were stained for 3-4 minutes at 37°C in the staining solution prepared by mixing 240 /A of Azur B (1 percent in H 2 O) and 200 n\ of Eosin (0.25 percent in methanol) in 20 ml of the phosphate buffer. Metaphases stained with G-l 1 were analyzed to determine the number of human chromosomes present in different microcell hybrids. The human chromosomes present in each hybrid were identified by characteristic Giemsa banding patterns.
In addition to the cytogenetic analysis, the hybrids also were analyzed for the expression of 30 isozymes previously assigned to different human chromosomes and used as signatures for chromosome identification in hybrid cells. Human and mouse type enzymes were distinguished by histochemical staining following electrophoresis in starch gel of crude cell extracts, using published procedures 15 .
DT was obtained from Connaught Lab-FIGURE 1 A shows metaphase spread of microceU hybrid R12-2 stained with Giemsa-11, with only one human chromosome present. S-human chromosome cutout from Giemsa banded metaphase of R12-2 is identified to be chromosome 5.
oratories, Willowdale, Ontario and purified as previously described 5 . Fragment A also was prepared as previously described". In addition, the purified fragment A was boiled for 20 minutes in 20 mM phosphate buffer, pH 7.2, containing 5 percent mercaptoethanol 28 . The purity of both DT and fragment A was confirmed by SDS-PAGE (21) . Pseudomonas aeruginosa exotoxin A was kindly made available by Dr. Leppla, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
DT was labeled with radioactive iodine by a modification of the lactoperoxidase method 22 . Thirty y.g of DT in 0.1 M phosphate buffer pH 7.6 was added to a vial containing lmCi of carrier free Na l25 I; then 0.3 j*g of lactoperoxdase (Sigma) was added and the total volume was brought to 50 fi\ with the phosphate buffer. To initiate the reaction, 2 Ml of H2O2 was added at 0 time and again after 3 minutes. The reaction was stopped after 6 minutes by the addition of 60 ti\ of cold 5 mM cysteine-hydrochloride. The I25 I-DT was separated from the free label on Sephadex G-25. The characteristic specific activity was 1-2 X 10~7 cpm/ftg DT.
All experiments described in this report were done in triplicates, unless stated otherwise. Cells were seeded in 24-well plates (0.5-1 X 10" 5 cells/well) in DME or MX and allowed to grow for 24 hours at 37°C in 10 percent CO 2 -90 percent air atmosphere. The cell layers were then washed with media to remove possible debris and unattached cells and fresh DME or MX containing indicated molar concentrations of toxins were added. Cells were replaced in the incubator for 20 hours for the expression of cytotoxicity. At the end of this incubation period, the growth medium was replaced by leucine-free medium to which 0.25 jiCi of 14 C-leucine was added and the cells were reincubated at 37°C for 120 minutes. The incorporation of 14 leucine in 5 percent TCA precipitable material was determined by washing the cell layers with ice cold DME without serum, followed by three washes with ice cold 5 percent TCA. The cells were lysed in 2 percent SDS and aliquots were taken for scintillation counting in a Beckman LS 250.
To study the effect of NH«C1 on DT toxicity cells were seeded in 24-well plates as already described. After 24 hours the growth medium was removed and fresh medium containing 10 mM NH4CI and varying concentrations of DT was added and the cultures were incubated for 2 hours. After this incubation period, the medium was replaced with phosphate buffer 32 , either at pH 4.5 or pH 7.2, containing 10 mM NH 4 C1 and the plates were reincubated for 15 minutes. Following this incubation, buffers were replaced with growth medium also containing 10 mM NH4CI. The incorporation of 14 C-leucine in a 5 percent TCA precipitable fraction was determined after overnight incubation as already described.
To measure binding, cells were seeded in 24-well plates as described. After 24 hours the growth medium was replaced with DME containing 10 mM Hepes buffer, pH 7.4 and chilled for 30 minutes on ice. Increasing amounts of 125 I-DT were then added to the cultures, either alone or in the presence of 200 fold higher concentrations of cold DT to measure specific binding. In preliminary experiments, binding was allowed to proceed for 6 hours or overnight at 4°C. However, we found that extensive rounding up of cells occurred during overnight incubations and therefore restricted the incubation time to 6 hours. Bound 125 I-DT was determined after washing of cell layers with ice cold medium (4 X 1 ml), solubilization in 0.2 N NaOH and determination of radioactivity in a Beckman 8000 7 counter.
Binding and uptake also were determined at 37°C in the presence of methylamine 24 . Cell layers in 24-well plates were incubated for 2-5 hours in DME containing 20 mM methylamine and 125 I-DT (0.1 jig), as well as different concentrations of cold DT. The cell associated l2i I-DT was determined after washing of cells with DME without serum (4 X 1 ml) and solubilization, as described for binding studies at 4°C.
Results and Discussion

Characterisation of the hybrid and identification of the transferred chromosome
In the G-ll staining procedure human chromosomes stain distinctively blue and have magenta centromeres, whereas mouse chromosomes stain magenta with blue centromeres 2 . Thus color differences in the chromosomes of these two species provide a quick method to determine the number of human chromosomes or chromosomal fragments present in mouse cells. Such analysis revealed that the hybrid R12-2, contained only a single human chromosome (Figure 1 ). Presence of a single human chromosome in R12-2 also was confirmed by in situ hybridization of a human specific repeated DNA probe (Blue 8) to the metaphase spreads of R12-2 (data not shown). The human chromosome present in R12-2 was identified to be chromosome 5 by Giemsa banding. The monochromosomal hybrid, R12-2, was further analyzed for the expression of 30 isozymes separable between mouse and human and assigned to different human chromosomes 18 . The only human form of enzymes expressed in R12-2 was found to be hexokinase-B (HEXB) assigned to human chromosome 5. Thus, combined together, the enzyme and cytogenetic data confirmed the identity of chromosome 5. Since the chromosome 5 was encoded with a selectable marker, it was maintained in R12-2 by selection. The experiments on the sensitivity to DT therefore were carried out on a cell population where every single cell contained human chromosome 5. Furthermore, possible variations (deviations) due to the presence of other human chromosomes were eliminated in the present analysis.
DT sensitivity
Although human cells are in general sensitive to DT, variations among different cell lines also have been reported 34 . Therefore it was necessary to establish the sensitivity of our cells. For purposes of comparison, an inhibitory index (ID50) was used, defined as the concentration of DT that inhibits protein synthesis by 50 percent after incubation of cells for 20 hours in the presence of the toxin 27 . Figure 2 depicts the sensitivity of MGH-1 to DT and also shows a comparison with RAG and R12-2. As can be seen, there was an almost 10~5 fold difference in the ID50 between the human and the mouse line. However, the ID50 of the monochromosomal hybrid was found within one order of magnitude of that of the donor.
Acquired sensitivity to DT in hybrid cells has been used to demonstrate the presence of human chromosome 5 since the gene(s) for DT sensitivity was first mapped to this chromosome in 1975 6 . However, there were no reports in the literature examining the parameters of sensitivity in the hybrids when the present work was started. In a very recent communication 19 , hybrids between human fibroblasts and Ehrlich ascites tumor cells were examined with respect to their sensitivity to DT and Pseudomonas exotoxin A (PE-A), that also ADP-ribosylates EF-2, but has different receptors than DT 13 . The authors found that hybrids that contained human chromosome 5 had increased sensitivity to DT, but it is not known what other chromosomes were present. It also was reported that Ehrlich ascites tumor cells were resistant to PE-A, but some hybrid clones had acquired sensitivity which, however, was not associated with the presence of human chromosome 5. Our mouse cell line and the monochromosomal hybrid had the same IDJO of PE-A as the human cell line, i.e., about 3 X 10~" M (data not shown).
Human chromosome 5 present in R12-2 cells carried a selectable marker, Ecogpt. The routine maintenance of these cells in MX medium assured the presence of chromosome 5 in every single cell. However, if cells were grown in DME without mycophenolic acid and xanthine the resistance of the hybrid culture against DT was found to increase (data not shown). Cytogenetic analysis of R12-2 cultured in nonselective medium for 48 hours revealed that 2 metaphases out of 25 analyzed did not contain chromosome 5, suggesting that changes in DT sensitivity were related to chromosome loss by segregation.
Comparison of fragment A and DT toxicity
While mouse cells are approximately as sensitive to DT as to fragment A, differences of 5-6 orders of magnitude between ID 50 of DT and fragment A have been demonstrated in some human cell lines 28 . As is summarized in Table I , also MGH-1 cells were about five orders of magnitude more sensitive to DT than to isolated fragment A. RAG cells showed a slightly higher sensitivity to DT than to fragment A. The sensitivity pattern of R12-2 cells was similar to that of the donor. Thus, the transfer of chromosome 5 was associated with a 4-log decrease in the ID50 of DT, while the ID50 of free fragment A did not change significantly.
It has been proposed that the entry of both DT and fragment A in resistant cells is through a shared mechanism, possibly nonspecific endocytosis 28 . This mechanism also would be present in sensitive cells but is not apparent because of the high sensitivity of these cells to the whole toxin molecule. By comparing the sensitivity of mouse cells to DT and fragment A before and after the transfer of chromosome 5, we have demonstrated that chromosome 5 regulates the events associated with the whole toxin molecule rather than fragment A.
Protective effect ofNHtCl and reversal at acid pH
In sensitive cells, DT is bound to specific cell surface receptors, endocytosed, and then released into the cytoplasm 8 -10 . Recently, it has been shown that the site of the release is an acidic prelysosomal compartment 23 , and agents that increase the pH of vesicles (e.g., NH4CI, chloroquine, monensin) protect cells against DT toxicity 9 ' 32 . After we had demonstrated the presence of DT sensitivity in the monochromosomal hybrid, it was of interest to determine its behavior with respect to NH4CI. The range of concentrations of DT necessary to demonstrate toxicity under the conditions used to study the NH4CI effect was determined in preliminary experiments. For MGH-1, as well as R12-2 cells this range started at about 5 X 10" 10 M while for RAG cells about 10~4 times higher concentrations of DT were needed. As shown in Figure 3 , NH4CI fully protected MGH-1 cells from the toxic effects of DT. The same degree of protection also was observed in the hybrid. Also RAG cells could be protected even in the presence of the very high concentrations of toxin needed to demonstrate inhibition of protein synthesis within the 2-hour incubation period. These results indicate that even if the steps to introduce DT into the cytoplasm may be distinct in MGH-1 and RAG cells, they are affected by changes of pH, and a similar phenomenon also is observed in the hybrid. Likewise, upon exposure to pH 4.5, a reversal of the protection against DT by NH4CI was observed in all three cell lines. These events do not depend on the presence of chromosome 5.
Binding and uptake of m I-DT
Two main theories, not necessarily exclusive, have been advanced to explain the differences between the toxicity of DT in resist- 25 . It was not possible to demonstrate specific receptors in our , donor cells at 4°C and therefore we measured the specific association of DT with cells " at 37°C in the presence of methylamine. As has been previously shown the presence of methylamine does not interfere with the ini--tial binding-internalization step but prevents the intracellular breakdown of the 125 I-DT * molecule 24 .
Typical results on the association of I25 I-DT with our cell lines are presented in Table  II . The amount of cold DT necessary to inhibit 125 I-DT association had been determined in preliminary experiments (data not ŝ hown). While a 200-fold excess of cold DT was sufficient for maximum suppression of the binding and uptake of labeled toxin in MGH-1 and R12-2 cells, even a 1000-fold excess failed to demonstrate any such effect in RAG cells, indicating that the DT association was nonspecific. In R12-2 cells specific •> association with DT was apparent, although the amount of 125 I-DT bound and internalized did not reach the levels found in MGH-1. The specific association of 125 I-DT with different cell lines both at 4°C and 37°C has been correlated with their sensitivity to DT. Thus, a 2-fold decrease in ID50 in sensitive cells was associated with a 4-to 5-fold in-» crease in the rate of binding or binding and uptake of '"I-DT 8 . These results agree well with ours where 5-to 10-fold differences between ID50 of MGH-1 and R12-2 cells (cf. Table I, Figure 2 ) were found.
As already stated, it has been known that DT sensitivity is associated with human chromosome 5 6 . However, the question whether the presence of chromosome 5 in a hybrid is sufficient for the full expression of such a sensitivity has not been investigated in a monochromosomal hybrid. In hybrids between human fibroblasts and Ehrlich ascites tumor cells containing human chromosome 5 and an unknown number of other chromosomes 19 , both the sensitivity to DT and the association of 125 I-DT in the presence of methylamine were similar to the human cell line. The same authors also report that in another clone not containing chromosome 5, but still being more sensitive to DT than Ehrlich ascites cells, no specific 125 I-DT association could be demonstrated 19 . These findings would suggest that for the full expression of DT sensitivity, additional information, not present on chromosome 5, may be necessary. However, the transfer of DT sensitivity into a human-mouse hybrid also depends on the characteristics of the mouse line. An important difference between the mouse lines used by the two laboratories is that our RAG cells are as sensitive to PE-A as the human donor cells while Ehrlich ascites tumor cells used by the other group of workers are resistant to PE-A 19 . Therefore the increase in DT sensitivity in one of their hybrid clones not containing chromosome 5 could be due to the transfer of information coding for a shared step of cellular processing of both DT and PE-A that is present in RAG cells but lacking in Ehrlich ascites tumor cells. The residual differences in DT sensitivity between MGH-1 and R12-2 cells may be due to the fact that chromosome 5 in our monochromosomal hybrid represents hemizygosity, or to unknown epigenetic phenomena of the hybrid.
Our data on DT association where both binding and uptake are recorded, do suggest that the surface molecules on RAG cells that interact only nonspecifically with DT are different from DT receptors on MGH-1 cells. This suggestion is reinforced by a recent report 16 . In a study on the properties of several monoclonal anti-DT antibodies, the investigators found that antibodies that protected the sensitive Vero cells against DT toxicity had no effect on the resistant L cells. Although the authors caution that the interpretation of their results is complicated by the possible steric effects of the large antibody molecules, their findings are consistent with our results and the suggestion that at least some mouse cell lines lack the receptors present on sensitive Vero cells.
Given that the presence of chromosome 5 is both necessary and sufficient for the expression of sensitivity to DT, the number of genes involved in this process is still unknown. The availability of a stable monochromosomal hybrid will permit us to generate clones containing sequentially decreasing segments of chromosome 5. These clones will provide materials for further investigation of the genetic basis of DT sensitivity.
